Motif Neurotech - Bryant McGill

# Motif Neurotech **Entity class:** Technology, concept, or ecosystem entity **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] ## Definition **Motif Neurotech** is represented in the supplied neurotechnology ecosystem graph through the source-qualified relationships below. This page preserves the graph's direction, predicate, evidence key, and epistemic status without treating technical similarity as ownership, funding, licensing, or organizational identity.  ## Relationships ### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 166 — `founded_by` → [[wiki/Jacob Robinson|Jacob Robinson]]** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. - **Edge 167 — `founded_by` → [[wiki/Kaiyuan Yang|Kaiyuan Yang]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Rice faculty co-founder. - **Edge 168 — `founded_by` → [[wiki/Sunil Sheth|Sunil Sheth]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 169 — `founded_by` → [[wiki/Sameer Sheth|Sameer Sheth]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 170 — `spun_out_of` → Rice University research / Rice Biotech Launch Pad** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. - **Edge 172 — `develops` → [[wiki/Digitally Programmable Over-Brain Therapeutic|Digitally programmable Over-brain Therapeutic (DOT)]]** — **VERIFIED**; evidence `MOTIF_2024`, `MOTIF_TRIAL_2026`. Miniature therapeutic brain stimulator. - **Edge 175 — `clinical_indication` → [[wiki/Treatment-Resistant Depression|treatment-resistant depression]]** — **VERIFIED**; evidence `MOTIF_TRIAL_2026`, `MOTIF_SERIESA`. - **Edge 176 — `regulatory_milestone` → FDA authorization to begin first clinical trial** — **VERIFIED**; evidence `MOTIF_TRIAL_2026`. 2026-04-28 Rice report; not commercial approval. - **Edge 177 — `Series_A` → 18.75 million USD** — **VERIFIED**; evidence `MOTIF_SERIESA`. Led by Arboretum Ventures; 2024. - **Edge 178 — `investor` → [[wiki/Arboretum Ventures|Arboretum Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 179 — `investor` → [[wiki/KdT Ventures|KdT Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 180 — `investor` → [[wiki/Satori Neuro|Satori Neuro]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 181 — `investor` → [[wiki/Dolby Family Ventures|Dolby Family Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 182 — `investor` → [[wiki/re.Mind Capital|re.Mind Capital]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 183 — `investor` → [[wiki/Divergent Capital|Divergent Capital]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 184 — `investor` → [[wiki/TMC Venture Fund|TMC Venture Fund]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 185 — `investor` → [[wiki/PsyMed Ventures|PsyMed Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 186 — `investor` → [[wiki/Empath Ventures|Empath Ventures]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 187 — `investor` → [[wiki/Capital Factory|Capital Factory]]** — **VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 188 — `ARIA_project` → [[wiki/Brain Mesh|Brain Mesh]]** — **VERIFIED**; evidence `ARIA_PROJECTS`, `ARIA_RICE`. Distributed network interface to mesoscale cortical circuits. - **Edge 192 — `technical_comparison` → [[wiki/Subsense BCI|Subsense]]** — **ANALYTIC**; evidence `MOTIF_2024`, `SUB_TECH`. Both exploit magnetoelectric physics in neurotechnology, but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. #### Epistemic boundary `VERIFIED`, `VERIFIED_SECONDARY`, `CORPUS`, `STRONG_TECHNICAL_LINEAGE`, `STRONG_TECHNICAL_CONVERGENCE`, `ANALYTIC`, and `UNRESOLVED` are retained as distinct relation states. An edge does not imply ownership, control, funding, licensing, technology transfer, or organizational identity unless its predicate and evidence state that relationship explicitly.   ### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 166 — `founded_by` → [[wiki/Jacob Robinson|Jacob Robinson]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. Rice faculty founder/CEO; direct personnel continuation from MOANA/N3. - **Edge 167 — `founded_by` → [[wiki/Kaiyuan Yang|Kaiyuan Yang]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Rice faculty co-founder. - **Edge 168 — `founded_by` → [[wiki/Sunil Sheth|Sunil Sheth]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 169 — `founded_by` → [[wiki/Sameer Sheth|Sameer Sheth]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Physician co-founder. - **Edge 170 — `spun_out_of` → Rice University research / Rice Biotech Launch Pad** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_SERIESA`. - **Edge 172 — `develops` → [[wiki/Digitally programmable Over-brain Therapeutic (DOT)|Digitally programmable Over-brain Therapeutic (DOT)]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_2024`, `MOTIF_TRIAL_2026`. Miniature therapeutic brain stimulator. - **Edge 175 — `clinical_indication` → [[wiki/Treatment-Resistant Depression|treatment-resistant depression]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_TRIAL_2026`, `MOTIF_SERIESA`. - **Edge 176 — `regulatory_milestone` → [[wiki/FDA authorization to begin first clinical trial|FDA authorization to begin first clinical trial]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_TRIAL_2026`. 2026-04-28 Rice report; not commercial approval. - **Edge 177 — `Series_A` → 18.75 million USD** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Led by Arboretum Ventures; 2024. - **Edge 178 — `investor` → [[wiki/Arboretum Ventures|Arboretum Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 179 — `investor` → [[wiki/KdT Ventures|KdT Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 180 — `investor` → [[wiki/Satori Neuro|Satori Neuro]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 181 — `investor` → [[wiki/Dolby Family Ventures|Dolby Family Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 182 — `investor` → [[wiki/re.Mind Capital|re.Mind Capital]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 183 — `investor` → [[wiki/Divergent Capital|Divergent Capital]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 184 — `investor` → [[wiki/TMC Venture Fund|TMC Venture Fund]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 185 — `investor` → [[wiki/PsyMed Ventures|PsyMed Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 186 — `investor` → [[wiki/Empath Ventures|Empath Ventures]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 187 — `investor` → [[wiki/Capital Factory|Capital Factory]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MOTIF_SERIESA`. Series A investor list. - **Edge 188 — `ARIA_project` → [[wiki/Brain Mesh|Brain Mesh]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `ARIA_PROJECTS`, `ARIA_RICE`. Distributed network interface to mesoscale cortical circuits. - **Edge 192 — `technical_comparison` → [[wiki/Subsense BCI|Subsense]]** — **PRIOR_NEUROTECH_ANALYTIC**; evidence `MOTIF_2024`, `SUB_TECH`. Both exploit magnetoelectric physics in neurotechnology, but Motif uses millimeter-scale implanted wireless power/stimulation while Subsense uses nanoparticle-scale distributed transduction. #### Epistemic boundary Primary-source, peer-reviewed, company-claim, preprint, analytic, inherited-corpus, dynamic-metric, source-version-conflict, and unresolved states remain distinct. A current primary source supersedes a stale uncertainty label without erasing the correction history. No edge establishes ownership, funding, licensing, program lineage, technology transfer, operational integration, or institutional control unless its predicate and evidence explicitly do so.